Apostle Inc is a biotechnology company developing a novel bioinformatics-enabled nanotechnology aimed for early cancer detection. This new approach will enable the early assessment of the cancerous signals in human peripheral blood plasma, which is believed to have a significant impact on the global healthcare landscape in both developed and developing  countries. Apostle has provided COVID-19 clinical diagnostic service to over 15,000 people since November 2020.